Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q1 2011
Executive Summary
For the first three months of 2011, medical device companies raised $733 million, with venture rounds bringing in $494 million. Two-thirds of the $3.9 billion in M&A activity came from Terumo's monstrous $2.6 billion cash takeover of US blood processing equipment maker CaridianBCT Holding. Buoyed by Opko Health's $105 million follow-on, the FOPO category represented almost half of the first quarter's in vitro diagnostics/research $370 million total. The stand-out IVD acquisition was Danaher's $6.8 billion takeover of publicly traded Beckman Coulter.
You may also be interested in...
Quest Highlights Diagnostics Pipeline As Key Component Of Celera Purchase
Quest Diagnostics will expand its molecular diagnostic product offerings and gain a substantial biomarker R&D pipeline while boosting its cardiovascular testing services business through the purchase of Celera for $344 million in cash.
Terumo Will Top Blood Transfusion Device Space With $2.6 Billion Acquisition
Diversified Japanese device maker Terumo will become the global leader in the blood transfusion product market with its planned $2.6 billion acquisition of privately owned CaridianBCT.
Accuray Buys TomoTherapy To Create 'Premier' Radiation Oncology Company
Radiosurgery device maker Accuray is acquiring radiation therapy developer TomoTherapy for $277 million in cash and stock to form “the premier radiation oncology company,” according to the firms.